Osteoarthritis
Conditions
Keywords
Osteoarthritis, knee
Brief summary
This registry study will compile information from patients that are scheduled to receive or have received Adipose Derived Regenerative Cells (ADRCs) prepared by the Celution device to treat osteoarthritis in the knee.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Males or females \> 18 years of age * Diagnosis of osteoarthritis in one or both knees with Kellgren Lawrence grade ≥ 2 at x-ray evaluation or MRI findings of degenerative changes * Pain with or without swelling in the affected area for \>4 months
Exclusion criteria
* Know spine or disc disease or symptomatic nerve impingement contributing to pain in the affected limb * History of documented nerve damage in the affected limb * Pregnant or lactating status. Pregnancy as determined by a positive pregnancy test prior to procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in knee pain as assessed by the knee injury and osteoarthritis outcome score (KOOS) | 90 days |
Secondary
| Measure | Time frame |
|---|---|
| Change in knee function as measured by the Lower Extremity Functional Scale | Days 7, 30, 90, 180 and 365 |
| Change in knee pain as assessed by the knee injury and osteoarthritis outcome score (KOOS) | Days 7, 30, 180 and 365 |
| Change in knee function as measured by Tegner Activity Scale | Days 7, 30, 90, 180 and 365 |
| Change in knee function as assessed by the Lysholm Knee Scoring Scale | Days 7, 30, 90, 180 and 365 |
| Change in WORMS scoring (Whole Organ MRI of the knee) | Days 180 and 365 |
| Change in knee pain assessed by VAS Assessments | Days 7, 30, 90, 180 and 365 |